Science Explorer Back to mapMap
Discussion
Researcher · Saitama Cancer Center · Japan

Hiroki Hara

Hiroki Hara publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Gastric Cancer Management and Outcomes, Esophageal Cancer Research and Treatment and Cancer Immunotherapy and Biomarkers.

ORCID 0000-0003-3881-9815 OpenAlex
World rank
#649,945
of 7,710,434 ranked researchers
Rank in Japan
#7,320
of 383,136
Works
489
Citations
17k
Citations per work
34.3
h-index
47
i10-index 140Top 4.3% in Oncology
Hiroki Hara

What does Hiroki Hara research?

Hiroki Hara's work is mostly in Medicine (66%), Biochemistry, Genetics and Molecular Biology (6%).

Health Sciences: 324 works · 66.2% of their workMedicine: 324 works · 66.2% of their workOncology: 118 works · 24.2% of their workPulmonary and Respiratory Medicine: 104 works · 21.2% of their workSurgery: 88 works · 17.9% of their workPathology and Forensic Medicine: 14 works · 2.9% of their workEverything else: 136 works · 27.9% of their workLife Sciences: 29 works · 5.9% of their workBiochemistry, Genetics and Molecular Biology: 29 works · 5.9% of their workCancer Research: 16 works · 3.2% of their workMolecular Biology: 13 works · 2.7% of their workTHEIR WORKHiroki Hara489works
Life Sciences6%Health Sciences66%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine32466.2%
  2. Everything else13627.9%
    1. Biochemistry, Genetics and Molecular Biology295.9%
  1. 1Oncology24% of their works
  2. 2Pulmonary and Respiratory Medicine21% of their works
  3. 3Surgery18% of their works
  4. 4Cancer Research3% of their works
  5. 5Pathology and Forensic Medicine3% of their works
  6. 6Molecular Biology3% of their works

Research topics

Which keywords describe Hiroki Hara's research?

The keywords of their largest research topics: Chemotherapy, Endoscopic Resection, Molecular Characterization, Gastric Cancer, Lymph Node Dissection, Cetuximab, Esophageal Carcinoma and Preoperative Chemoradiotherapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Chemotherapy2433 topics
  2. Endoscopic Resection2432 topics
  3. Molecular Characterization1592 topics
  4. Gastric Cancer1361 topic
  5. Lymph Node Dissection1361 topic
  6. Cetuximab1072 topics
  7. Esophageal Carcinoma1071 topic
  8. Preoperative Chemoradiotherapy1071 topic
  9. Immune Checkpoint Blockade901 topic
  10. PD-1 and PD-L1901 topic
  11. Fluorouracil841 topic
  12. KRAS Mutations841 topic
  13. Targeted Therapy722 topics
  14. ALK Inhibitors431 topic
  15. EGFR Mutations431 topic
  16. Cancer Genomics291 topic
  17. Mutational Signatures291 topic
  18. Hereditary Syndromes231 topic
  19. Human Papillomavirus231 topic
  20. Microsatellite Instability231 topic
  21. Oropharyngeal Cancer231 topic

Where does Hiroki Hara work?

Hiroki Hara's main affiliation in the publication record is Saitama Cancer Center, Japan.

How many publications and citations does Hiroki Hara have?

OpenAlex counts 489 works and 16,755 citations for Hiroki Hara, an h-index of 47, ranking #649,945 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Hiroki Hara

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Hiroki Hara. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.